Search Results (993)

Background: To date, several studies have confirmed the fact that over 700 species of microbiota interacts with host, modulating immunity, controlling the homeostasis environment, and thus maintaining systemic condition. Dysbiosis in the subgingival biofilm can initiate chronic inflammation of the gingiva, potentially progressing to periodontitis. Advances in DNA sequencing analysis of the subgingival microbial community have shown that periodontal treatment causes a microbial shift in subgingival plaque, affecting the taxonomic composition (disease- and health-associated taxa). Yet, none of these have been investigated in Indonesia. Objective: The objective was to profile the composition of oral microbiome in Indonesian population with healthy, gingivitis, and periodontitis status. Further, we analyzed the subgingival bacterial alteration following the therapy in periodontitis group. Methods: Twelve subjects consisting of healthy, gingivitis, and periodontitis patients were included. Additionally, the periodontitis group was observed at baseline, 1-month, and 3-month. Subgingival dental plaque were sampled and 16S rRNA NGS analysis was performed. Alpha (Chao1, Shannon, and Simpson indices) and beta diversity (PCoA plots based on Bray–Curtis dissimilarity) were observed. Microbiota composition at the genus and species levels was analyzed. Results: No statistically significant differences (p > 0.05) were found for Chao1, Shannon, and Simpson indices amongst groups and in periodontitis patients across the observation. At the genus level, PCoA plots based on Bray–Curtis dissimilarity revealed that the clinical status accounted for 21.9% of the total variation (R² = 0.219, p = 0.197), while at the species level, it accounted for 19.8% (R²= 0.198, p = 0.281). Periodontitis samples across all timepoints showed no distinct clustering at either the genus 7.6% (R² = 0.076 p = 0.097) or species levels 9.7% (R² = 0.097 p = 0.995). Top five subgingival microbiota at the genus and species levels in all groups showed definite pattern of composition. Although no significant association was found (p > 0.05), it described that Veillonella parvula, Campylobacter gracilis, and Capnocytophaga granulosa were more abundant in healthy subjects than in gingivitis and periodontitis. Prevotella oris and Selenomonas noxia were less abundant in healthy subject than in gingivitis and periodontitis. In periodontitis subjects, Prevotella intermedia was increased by the therapy at 1 month and reduced again at 3 months. On the other hand, Capnocytophaga granulosa was increased by the therapy at 1 and 3 months. Hoylesella loescheii was reduced by the time. Porphyromonas gingivalis was reduced at 1 month and increased again at 3 months. Discussion: The result showed that the number of alpha diversity was notably higher in the gingivitis and periodontitis groups compared to health group, supporting a trend toward increased community richness and evenness in diseases states. The microbial richness and evenness remained relatively stable across the evaluated periods within periodontitis cohort. Oral microbial composition defines the periodontal status and disease. More abundance of Red Complex bacteria is associated with disease-associated condition. Pathogen re-colonization may occur 3 months after the therapy. Conclusions: These findings suggest that maintaining health-associated microbiome may be beneficial to the clinical status. Periodontal recall may be addressed from 1 to 3 months after the therapy to avoid bacterial re-colonization. Suppressing bacterial dysbiosis and regulating periodontal homeostasis are the main key in managing periodontal treatment. Full article

Endophytic bacteria associated with medicinal plants represent a potential source of microorganisms with useful enzymatic and antagonistic properties. In this study, 14 bacterial isolates were recovered from the leaves, roots, flowers, and petioles of Inula helenium and screened for morphological, biochemical, and hydrolytic characteristics. Isolate IH-B3, which showed the most pronounced starch- and casein-hydrolysis zones during preliminary screening, was selected for further characterization. MALDI-TOF mass spectrometry assigned the isolate to Bacillus subtilis with an identification score of 2.26, and the strain was designated B. subtilis UzMU25. Its 1444 bp 16S rRNA gene sequence was deposited in GenBank under accession number PZ593820. The strain was catalase- and lecithinase-positive but gelatinase- and hemolysis-negative, and it grew at pH 6.5 and in the presence of horse bile under the qualitative assay conditions used. Hydrolysis-zone diameters ranged from 46 to 52 mm for amylase, 34 to 42 mm for protease, and 10 to 16 mm for lipase activity. In direct antagonism assays, UzMU25 inhibited all six bacterial and fungal test organisms, producing inhibition zones of 26–36 mm. Biofilm biomass varied with incubation time and reached its highest corrected OD₅₉₀ value at 12 h (0.780 ± 0.025). Antibiotic-disc testing showed a 10 mm inhibition zone for vancomycin, indicating reduced susceptibility under the applied conditions and requiring further investigation of its genetic basis and potential transferability. No mortality was observed during the preliminary acute oral study following administration of the tested preparation at doses up to 10,000 mg kg⁻¹, and no visible dermal or conjunctival irritation was detected. Overall, UzMU25 exhibited preliminary enzymatic, antagonistic, and biofilm-forming characteristics of biotechnological interest. However, whole-genome antimicrobial-resistance screening and more comprehensive phenotypic and toxicological evaluations are required before the strain can be recommended for probiotic or other practical applications. Full article

Background: Motor and intellectual disabilities (MIDs) belong to a restricted and vulnerable social group with health restrictions for maintaining and preserving adequate oral health. Silver nanoparticles (AgNPs) have appeared as an encouraging therapy due to their excellent antimicrobial effects; however, scientific information on the antimicrobial effectiveness of AgNPs against bacteria in patients with MIDs remains limited. This study aimed to evaluate the antimicrobial substantivity of AgNPs in oral bacteria from patients with and without MIDs. Methods: Fifty-four oral biofilm samples were obtained from 26 participants with MIDs and 28 participants without MIDs. The microbial inhibition activity and the antimicrobial substantivity of AgNPs were determined. The antibiofilm activity of the AgNPs was explored using scanning electron microscopy (SEM). Results: The AgNPs displayed uniform size distributions (9.8 ± 1.7 nm) and electrical charges in surface particles that limit particle clustering (−39.8 ± 3.3 mV). The AgNPs were more effective than chlorhexidine (CHX) in eliminating bacteria from oral biofilms derived from both MID and non-MID patients (p < 0.05); therefore, the antimicrobial substantivity of the AgNPs was statistically better than deionized water but lower than CHX at specific exposure times (p < 0.05). The antimicrobial effectiveness of AgNPs at even low concentrations was associated with the type of oral biofilm, the type of antimicrobial solution, and, in some cases, gender. SEM images indicate a clear alteration in oral biofilm structure when AgNPs were applied. Conclusions: AgNPs exhibited significant potential to limit oral bacterial proliferation from microbial biofilms while contributing to the maintenance of oral condition in individuals with MIDs. Full article

Acinetobacter baumannii, particularly colistin-resistant strains, represents a major therapeutic challenge because of multidrug resistance, biofilm formation, and limited treatment options. This study investigated the antibacterial, antibiofilm, immunomodulatory, and therapeutic potential of Withania somnifera ethanolic root extracts (WSEEs) against drug-sensitive (DS) and colistin-resistant (CR) A. baumannii. WSEE exhibited concentration-dependent antibacterial activity, with MIC/MBC values of 125/250 μg/mL against the DS isolate and 250/500 μg/mL against the CR isolate. Time–kill analysis demonstrated bactericidal activity at 250 μg/mL, and WSEE significantly reduced the biomass of preformed biofilms. In cyclophosphamide-induced leukopenic mice, oral administration of WSEE (100 and 200 mg/kg) restored leukocyte counts and significantly reduced pulmonary bacterial burden following infection with both isolates. The higher dose (200 mg/kg) achieved survival rates of 90% and 70% in mice infected with the DS and CR isolates, respectively, compared with 50% and 30% in the corresponding colistin-treated groups. WSEE also significantly decreased serum levels of the pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), indicating attenuation of infection-associated inflammation. Biochemical analyses further showed that WSEE did not produce detectable hepatotoxicity or nephrotoxicity under the experimental conditions. Collectively, these findings demonstrate that WSEE possesses antibacterial, antibiofilm, anti-inflammatory, and immunomodulatory activities and provides therapeutic benefit in experimental A. baumannii infection. These results support the potential of WSEE as a complementary therapeutic strategy against multidrug-resistant A. baumannii, while further mechanistic, pharmacokinetic, and translational studies are needed to validate its clinical potential. Full article

Periodontitis and dental caries remain among the most prevalent chronic diseases, and their local treatment is limited less by the choice of active agent than by the difficulty of sustaining therapeutic concentrations against salivary and crevicular clearance, the mucosal barrier and the biofilm matrix. This narrative review (PubMed/MEDLINE, Scopus, Web of Science; 2010–2026; 118 sources) maps five mechanistic classes—mucoadhesive, in situ gelling, stimuli-responsive, nano-/microparticulate and biomimetic—alongside marketed sustained-release products onto the specific barrier each addresses and onto an explicit translational gradient. The barriers are quantified rather than described: a pocket of ≈0.5 µL perfused at ≈20 µL/h turns over some 40 times hourly, giving an intra-crevicular half-life of about one minute, and the inflamed pocket is neutral-to-alkaline (pH 7.4–8.5), so acid-triggered release is a cariogenic and not a periodontal strategy, whereas alkaline-triggered release remains an open design space. A dose calculation from these figures identifies payload potency and deliverable mass, not carrier retention, as the binding constraint on phytocompound delivery. Because no single class overcomes all barriers, hybrid nano-in-macro architectures are analysed as the structural solution. Measured against a marketed benchmark of ≈0.3 mm additional probing-depth reduction, progress now depends on consolidation rather than on novelty. Full article

Azithromycin is widely used in dentistry as a systemic antibiotic, particularly for odontogenic infections and as an alternative in patients with β-lactam hypersensitivity. Beyond its antimicrobial activity, azithromycin possesses unique pharmacokinetic, anti-inflammatory, immunomodulatory, and anti-biofilm properties. Together with growing concerns regarding antimicrobial resistance and antibiotic stewardship, these characteristics have stimulated interest in local drug-delivery strategies that may reduce systemic antibiotic exposure while maintaining therapeutic efficacy. This narrative review evaluates the rationale, potential clinical applications, and current evidence supporting local azithromycin delivery in dentistry. The available literature on azithromycin pharmacology, systemic dental use, immunomodulatory mechanisms, biofilm-related effects, local drug-delivery systems, safety, and regulatory considerations was critically reviewed. Current evidence suggests that locally delivered azithromycin may achieve high drug concentrations at the target site, enhance anti-biofilm activity, modulate local inflammation, and minimize systemic exposure. Potential applications include periodontitis, peri-implant diseases, persistent endodontic infections, oral surgery, and regenerative procedures such as bone augmentation and maxillary sinus floor elevation. Emerging delivery platforms, such as hydrogels, thermoresponsive gels, nanoparticles, and chitosan-based systems, further support the feasibility of this approach. Experimental findings also indicate that azithromycin may inhibit osteoclast activity, suggesting additional benefits for bone preservation and regenerative healing. Despite these promising findings, current evidence remains limited and is derived mainly from preclinical studies and small clinical investigations. Further translational research and well-designed randomized controlled trials are needed to establish the safety, efficacy, and optimal clinical role of locally delivered azithromycin in evidence-based dental practice. Full article

Helicobacter pylori is one of the most common bacterial pathogens in humans and the primary etiological agent of chronic gastritis, peptic ulcer disease, and gastric cancer. Its ability to establish persistent gastric colonization relies on multiple virulence factors, including adhesins, urease, cytotoxins, motility, outer membrane vesicles, and biofilm formation, which collectively promote bacterial survival, chronic inflammation, and treatment failure. The increasing prevalence of antibiotic-resistant H. pylori strains has intensified the search for therapeutic strategies targeting both bacterial viability and virulence. Berberine (BBR), a natural isoquinoline alkaloid, has emerged as a promising candidate because of its antibacterial, anti-inflammatory, and antioxidant properties. Increasing evidence derived from native berberine, its derivatives, and berberine-based formulations indicates multifaceted anti-H. pylori activity, including direct antibacterial effects, inhibition of virulence determinants, and modulation of host inflammatory responses. This review summarizes current knowledge on the epidemiology and pathogenic mechanisms of H. pylori and provides a comprehensive overview of the available evidence regarding the anti-H. pylori pharmacological profile of BBR-based compounds. Particular attention is given to their effects on bacterial adhesion, motility, urease activity, efflux pump function, biofilm formation, and host inflammatory signaling pathways. The review also discusses findings from preclinical and clinical studies supporting BBR-based strategies as adjuncts to conventional eradication therapies. In addition, recent advances in nanotechnology-based drug delivery systems designed to overcome the poor oral bioavailability of BBR and improve its therapeutic efficacy against H. pylori are highlighted. Full article

High-throughput metagenomic sequencing and advances in mucosal immunology have refuted the traditional physiological concept of a sterile respiratory tract. The oral cavity has been recognized as a dynamic determinant of systemic health. As in other parts of the body, recent studies also suggest that pulmonary health may be linked to oral health. Under eubiotic conditions, the oral microbiome maintains local immunological homeostasis and colonization resistance. Oral dysbiosis, characterized by sequential shifts in microbial communities and the proliferation of the pathogenic red complex (Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia), induces a state of chronic systemic inflammation, potentially involved in an infectious axis between the oral cavity and the lung. This review evaluates the tripartite systemic pathways of metastatic infection, metastatic injury, and metastatic inflammation that govern the translocation of oral pathobionts and their bioactive components, including lipopolysaccharides, outer membrane vesicles, and matrix metalloproteinases, to the lower respiratory tract via microaspiration and hematogenous circulation. The clinical implications across the chronic respiratory disease spectrum are examined, with a focus on how deficits in oral microbial diversity influence chronic obstructive pulmonary disease (COPD) pathogenesis, modulate the pulmonary virome and mycobiome, and stimulate maladaptive trained immunity. Furthermore, the contribution of biological aging is assessed, highlighting the roles of immunosenescence, inflammaging, and physiological reflex decline within the broader mucosal continuum. Finally, the clinical translation of this axis is analyzed, emphasizing the integration of saliva-based point-of-care nano-theranostics, metatranscriptomic profiling, and targeted interventions—such as professional oral biofilm management in intensive care settings and precision microbiome engineering—to preserve respiratory function and restore immune homeostasis. Full article

Introduction: One of the fundamental principles of modern medicine, including dentistry, is prevention. However, if treatment is not initiated, tooth loss can occur, necessitating the use of dental prostheses to restore the function and aesthetics of the stomatognathic system. The oral microbiome is a complex ecosystem that is sensitive to external factors, including the biomaterials used to manufacture dental prostheses. Objectives: This narrative literature review aims to identify and compare the effects of various metal alloys used in dentistry, specifically high-precious (gold), precious (silver–palladium) and base (cobalt–chromium and nickel–chromium) alloys, as well as titanium, on the balance of the oral microbiome and biofilm formation. Results: The analysis indicates that gold, silver and palladium alloys demonstrate the most favourable biocompatibility and antibacterial properties, significantly reducing biofilm accumulation. Titanium and titanium-based alloys generally exhibit neutral properties under healthy conditions, although their biocorrosion products can alter the microbial environment in pathological states such as peri-implantitis. In contrast, base metal alloys (cobalt–chromium and nickel–chromium) are highly susceptible to biocorrosion in acidic environments, which can encourage the growth of bacteria that cause tooth decay and inflammation, potentially exacerbating oral dysbiosis. Conclusions: The selection of materials plays a critical role in maintaining oral microbial homeostasis and preventing plaque-related diseases. High-noble alloys and titanium are more biocompatible than base metal alloys. However, further long-term clinical trials and multi-species biofilm models are needed to fully understand these interactions between materials and microbes. Full article

Fermented foods contain diverse microorganisms that may influence oral microbial ecology and contribute to oral health. This narrative review aimed to examine the current evidence regarding microorganisms present in fermented foods and their role in oral health promotion. Twenty relevant clinical, experimental, observational, and review studies published between 2016 and 2026 were identified through a structured literature search and critically synthesized according to major thematic areas, including oral microbiota modulation, dental caries prevention, periodontal health, probiotic delivery systems, and evidence from review articles. The findings appear to indicate that fermented food-derived microorganisms may reduce cariogenic and periodontal pathogens, modulate oral biofilms, improve gingival health, and promote microbial homeostasis. Yogurt, kefir, fermented dairy products, and kimchi-derived microorganisms were the most frequently investigated sources. Emerging evidence further suggests that the benefits of these microorganisms are linked to ecological regulation of the oral microbiome and host–microbe interactions rather than direct antimicrobial activity alone. Microorganisms associated with fermented foods may therefore represent promising functional dietary components for supporting oral health and complementing preventive oral healthcare strategies. Further well-designed clinical studies are needed to establish strain-specific recommendations and explore the potential of postbiotic applications in dentistry. Full article

Streptococcus mutans is the primary etiological agent of dental caries due to its ability to form acidogenic biofilms on tooth surfaces. Natural monoterpenes have attracted considerable interest as potential antibiofilm agents for oral healthcare. The present study investigated the antibiofilm activity and possible mechanism of action of (+)-endo-borneol isolated from the essential oil of Achillea millefolium against S. mutans. The chemical composition of the essential oil was characterized by gas chromatography–mass spectrometry (GC–MS), and (+)-endo-borneol was isolated by chromatographic separation. Antibiofilm activity was evaluated using the crystal violet biofilm assay, while antimicrobial activity was determined by minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. The influence of subinhibitory concentrations of (+)-endo-borneol on the expression of the biofilm-associated genes gtfB and yycF was assessed by quantitative real-time PCR. Molecular docking was performed to investigate ligand–protein interactions, using a ligand geometry pre-optimized by density functional theory (DFT, B3LYP/6-31G**). The essential oil inhibited S. mutans biofilm formation by up to 98%, whereas isolated (+)-endo-borneol reduced biofilm biomass by 97–98% at concentrations of 2–10 mg/mL. The MIC and MBC values of (+)-endo-borneol were 2.5 and 5.0 mg/mL, respectively. Gene expression analysis demonstrated that subinhibitory concentrations of (+)-endo-borneol modulated the transcription of gtfB and yycF, indicating activation of bacterial regulatory responses. Molecular docking revealed favorable binding of (+)-endo-borneol to biofilm-related protein targets. These findings demonstrate that (+)-endo-borneol is a promising natural antibiofilm compound with potential application in the development of novel preventive and therapeutic oral healthcare products targeting S. mutans biofilms. Full article

Background/Objectives: Three-dimensionally (3D) printed resins are increasingly used for removable orthodontic appliances, but how their mechanical reliability changes in the oral environment is unclear. This study evaluated the effect of bio-ageing environment and material type on the biaxial flexural strength and Weibull reliability of one conventional acrylic resin (Orthocryl, OC) and two 3D-printed photopolymer resins (BioMed Clear, BMC; and KeySplint Hard, KH). The Weibull modulus (m) reflects how consistent, or predictable, the strength is among specimens, independent of its average value. Methods: Disc specimens (n = 32) were aged for 24 h at 37 °C in pooled human saliva, a Streptococcus mutans biofilm, or water, and the biaxial flexural strength was measured by the piston-on-three-balls method (1 mm/min). Data were analysed with two- and three-parameter Weibull statistics to estimate the Weibull modulus (m), characteristic strength (σ₀), strength at 5% failure probability (σ₅%), and threshold strength (σ_μ), with model selection guided by the Akaike Information Criterion. Results: Biofilm exposure lowered m while σ₀ was preserved: m fell from 9.96 (saliva) and 7.98 (water) to 1.95 for OC, and from 17.61 and 13.01 to 2.62 for BMC, whereas σ₀ stayed near 55 MPa (OC) and 64 MPa (BMC). Under biofilm the modulus of all three converged to low values (1.4–2.6), abolishing the differences among materials; OC and BMC required a three-parameter model only after biofilm (σ_u ≈ 41 MPa), whereas KH required it in every environment (σ_u = 28.9–38.7 MPa). Conclusions: Biofilm ageing mainly reduced strength predictability, while characteristic strength was largely preserved. This indicates that flexural strength alone may be insufficient to qualify resins for removable appliances, and that printed resins studied here are not inherently superior or inferior to conventional acrylic. Full article

Background/Objectives: In this study, nanoemulsions containing Thymus vulgaris (TV) and Rosmarinus officinalis (RO) essential oils (EOs) were prepared and characterized, and their antibacterial, antifungal, and antibiofilm activities were evaluated against some oral pathogens. Methods: Three nanoemulsions containing 5% TV-EO (F1), 5% RO-EO (F2), and a combination of 2.5% TV-EO and 2.5% RO-EO (F3) were prepared by emulsification followed by high-speed homogenization. Results: Gas chromatography–mass spectrometry coupled with flame ionization detection (GC-MS-FID) analysis revealed linalool (79.51%) as the major constituent of TV-EO and eucalyptol (58.13%), together with camphor (10.80%), as the predominant compounds of RO-EO. All nanoemulsions exhibited nanosized droplets, low polydispersity index (PDI) values (<0.3), and moderate to high colloidal stability. Transmission electron microscopy (TEM) analysis revealed predominantly spherical droplets in all formulations (F1–F3). All formulations exhibited antimicrobial activity against Streptococcus mutans, Lactobacillus acidophilus, Enterococcus faecalis, and Candida albicans. Among the tested formulations, F2 showed the strongest antibacterial activity, whereas F3 exhibited the highest antibiofilm activity against mature S. mutans biofilms, achieving approximately 80% inhibition, comparable to chlorhexidine (CHX). Although F3 possessed the smallest droplet size, its antimicrobial activity was lower than that of F2, suggesting that biological activity was influenced not only by droplet size but also by EO composition. Conclusions: These findings demonstrate the potential of TV-EO and RO-EO nanoemulsions as promising natural alternatives for mouthwash formulations and highlight the importance of EO composition in determining antimicrobial and antibiofilm efficacy. Full article

Background: Dental caries is a highly prevalent, biofilm-mediated disease characterized by microbial dysbiosis, excessive acid production, and progressive enamel demineralization. Although traditionally managed through restorative treatment, increasing attention has shifted toward preventive strategies focused on modulation of the oral microbiota and maintenance of ecological balance within the oral cavity. Methods: This narrative review summarizes current evidence regarding the ecological and mechanistic basis of dental caries and microbiota-centered prevention strategies. Literature published between January 2000 and March 2026 was retrieved from PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar using keywords related to dental caries, oral microbiota, cariogenic bacteria, biofilms, probiotics, prebiotics, salivary diagnostics, metabolomics, quorum sensing, and artificial intelligence. Results: Current evidence demonstrates that dental caries is driven by ecological shifts favoring acidogenic and aciduric microorganisms within cariogenic biofilms. Emerging preventive approaches include dietary modification, oral hygiene optimization, probiotics, prebiotics, synbiotics, and functional dietary agents aimed at restoring microbial homeostasis and inhibiting cariogenic biofilm maturation. In addition, advances in salivary microbiome profiling, metabolomics, artificial intelligence-assisted predictive modeling, and smart responsive materials have shown promising potential for improving early diagnosis, risk assessment, and personalized prevention strategies. Conclusions: Microbiota-based approaches represent a promising paradigm shift in dental caries prevention by emphasizing ecological modulation rather than pathogen eradication alone. Continued interdisciplinary research integrating microbial ecology, diagnostics, biomaterials, and digital technologies may facilitate the development of personalized and preventive oral healthcare strategies. Full article

Dysbiosis-related oral biofilm diseases, particularly dental caries and periodontal diseases, pose major global health challenges because ecological shifts within oral microbial communities enhance biofilm virulence, resilience, and host inflammatory responses. Cannabidiol (CBD), a non-psychoactive phytocannabinoid with antimicrobial, antibiofilm, immunomodulatory, and antioxidant properties, has attracted increasing interest as an investigational, ecology-oriented adjunct for oral health applications. This narrative review evaluates current antibiofilm, antivirulence, and host response evidence for CBD in dysbiosis-related oral biofilm diseases, with emphasis on dental caries and periodontal diseases and selected supportive evidence from other oral biofilm-associated conditions. Current evidence suggests that CBD can inhibit biofilm formation, attenuate cariogenic and fungal virulence traits, modulate periodontal inflammation and immunity, and support tissue-protective responses. However, most evidence remains preclinical and model-dependent, particularly in caries research, and CBD’s hydrophobicity, limited stability, uncertain dose windows, and incomplete microbiome-level evidence remain major barriers to translation. Future studies should clarify CBD’s ecological effects on oral microbial communities, define clinically relevant dosing and exposure timing, and develop oral-retentive delivery systems. Full article